Aug 2026· IEEE Transactions on Computational Biology and Bioinformatics· Vol 23, pp. 2257-2268· 0 citations· 41 references
Medicine
TL;DR
KGDDA is proposed, a multimodal framework designed for drug-disease association prediction that synergistically integrates KGs with medical ontologies, enabling the adaptive capture of intricate drug-disease interactions.
Abstract
Drug repurposing represents a cost-effective strategy to identify novel therapeutic applications for existing pharmaceuticals, circumventing the protracted timelines of traditional drug discovery. While knowledge graph (KG) based methods excel at integrating heterogeneous biomedical data, they often struggle to harmonize high-level domain knowledge with fine-grained molecular mechanisms. We propose KGDDA, a multimodal framework designed for drug–disease association prediction that synergistically integrates KGs with medical ontologies. By leveraging an attention-driven fusion mechanism, KGDDA dynamically merges contextual topological embeddings with ontology-derived priors, enabling the adaptive capture of intricate drug–disease interactions. Extensive evaluations on two benchmark datasets demonstrate that KGDDA consistently outperforms state-of-the-art baselines in both predictive accuracy and generalization. Furthermore, case studies on head and neck cancer and small cell lung cancer validate KGDDA’s ability to provide actionable mechanistic insights, highlighting its potential to accelerate therapeutic discovery and precision medicine.
SGTL-DDA is proposed, a novel graph transformer framework designed to incorporate structural information and domain-specific knowledge from heterogeneous biological information networks (HBINs) that successfully identifies both known therapeutics and novel repositioning candidates, supported by molecular docking result...
Bowei Zhao, Hui Zhao, Yu-An Huang et al.· IEEE transactions on computa...· 0 citations
MolADR is proposed, a multiscale complementary learning framework that integrates GNN-based KG learning with dual-granularity molecular cross-attention modeling to combine macro-level biomedical associations with microlevel molecular interaction cues, suggesting its ability to highlight chemically plausible atoms and f...
Yi-Fan Qi, Qing-Wen Ren, Chen-Xu Wang et al.· Journal of Chemical Informat...· 0 citations
Empirical evaluation and robustness experiments show that M2DDI maintains high predictive accuracy even when modality-specific information is partially missing, outperforming existing methods under similar conditions and establish M2DDI as an effective and mechanism-aware solution for comprehensive DDI prediction.
Runqing Xu, Siyi Liu, Hao-Yang Li et al.· Proceedings of the 32nd ACM...· 0 citations
Results indicate that FragSyn, through the synergistic design of fragment-level representation and cellular context awareness, provides an effective and interpretable new approach to synergistic drug combination prediction.
Li-Feng Shao, Jianqiang Sun, Hong-Zhan Ma et al.· Journal of Chemical Informat...· 0 citations
L2aCo is a model-agnostic knowledge alignment framework that leverages large language models as external biomedical knowledge sources to expand the effective knowledge boundary for drug combinations and substantially improves generalization for cold-start and long-tail cell lines.
Tengfei Ma, Yuqin He, Zhong-Hao Ren et al.· Proceedings of the 32nd ACM...· 0 citations
Experiments demonstrate that HSAF-DDI achieves superior overall performance compared to state-of-the-art methods, indicating the critical role of fine-grained biological features in improving the DDI prediction performance.
Xiaoli Lin, Si-Yuan Zhang, Bo Li et al.· Journal of Chemical Informat...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.